Studies using platelet-activating factor (PAF) antagonists have indicated that PAF is involved in neuronal loss following human immunodeficiency virus infection [7], in kainic acid-induced epilepsy models [8] and in AD [9]. This evidence concerns the gene PCLAF and epilepsy.